by Susan Berke Fogel, Pro-Choice Alliance for Responsible Research (PCARR)
and Francine Coeytaux, Public Health Institute (PHI)
and Marcy Darnovsky, Center for Genetics and Society
and Lisa Ikemoto, University of California-Davis School of Law
and Judy Norsigian, Our Bodies, Ourselves
April 23, 2014 - 9:10 am
A recent RH Reality Check piece treated the vexing question of commercial surrogacy as a litmus test for feminists. For us at Pro-Choice Alliance for Responsible Research, we believe that contract pregnancy can’t be understood in such a simplistic framework.
What is a woman to do if neither her plan A (birth control) nor her plan B (the morning-after pill) worked? Wouldn’t it be great if she had a plan C—a medicine similar to these other pills that would start her period and end her anxieties? Such a thing exists, and it should be available to all women.
There is much we can learn from our sisters in the Global South who, rather than trying to gain access to services that all too often do not exist or fail to treat them well, are obtaining pills to induce abortion and taking them at home without seeing a health provider.
We applaud the California governor’s veto of AB 926, which would have permitted researchers to pay women for their eggs. His decision was based, in part, on the fact that the risks to women who provide eggs outweigh the potential scientific benefits.
If we have a cheap and readily available drug that can prevent and treat the two largest causes of maternal mortality worldwide—postpartum hemorrhage and unsafe abortion—why have we not taken more advantage of it?
by Francine Coeytaux, Public Health Institute (PHI)
May 7, 2010 - 8:00 am
As we prepare to honor our mothers, I am struck by the difference between my mother’s childbearing experiences and my own. I had many choices; she had few.